跳至主要内容
临床试验/JPRN-C000000295
JPRN-C000000295已完成未知

A randomized non-inferiority trial of valganciclovir versus intravenous ganciclovir as preemptive therapy for cytomegalovirus infection in living donor liver transplantation. - A randomized non-inferiority trial of valganciclovir versus intravenous ganciclovir for cytomegalovirus infection in living donor liver transplantation

Artificial Organ and Transplantation Division, Tokyo University Hospital0 个研究点目标入组 140 人开始时间: 2005年12月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients complicated with severe or uncontrollable diarrhea, or malabsorption. 2)Drug allergy to valganciclovir, ganciclovir or other other drugs(acyclovir, and valacyclovir) similar in structures with those two drugs. 3)Patients complicated with severe diseases including other infectious diseases. 4)Pregnat women or women of childbearing potential or brestfeeding 5)Patients who received a graft from ABO incopatible donor. 6)Patients for HIV infection 8)Patients who have symptoms due to cytomegalovirus infection at the onset of positive cytomegalovirus pp65 antigen assay. 9)Patients who are judged as inappropriate by a doctor in attendance for some medical reasons.

研究者

发起方
Artificial Organ and Transplantation Division, Tokyo University Hospital

相似试验